Rivista di formazione e aggiornamento professionale del pediatra e del medico di base, fondata nel 1982. In collaborazione con l'Associazione Culturale Pediatri.
Login Abbonamenti Pubblicazioni Carrello Registrazione Perché registrarsi? Contatti

Vaccinare

Reazioni avverse osservabili dopo vaccinazione

Adverse events following immunization

Patrizia Felicetti1, Francesco Trotta1, Carmela Santuccio1, Antonella Biasiotta1, Pasquale Marchione1, Caterina Rizzo2, Giovanna Zanoni3, Roberta Opri3 per il Gruppo di Lavoro per la Vaccinovigilanza

1Agenzia Italiana del Farmaco (AIFA)
2Centro Nazionale di Epidemiologia, Sorveglianza e Promozione della Salute (CNESPS), Istituto Superiore di Sanità (ISS)
3Azienda Ospedaliera Universitaria Integrata di Verona

Settembre 2016 - pagg. 449 -452

Abstract
To recognize adverse reactions after immunization is crucial to define their clinical features, to evaluate the diagnosis based on clinical history of patient, and consider whether the event meets a known case definition. In order to facilitate the recognition of adverse reaction the Italian Working Group for vaccine surveillance at the Italian Medicines Agency has developed a guide for the evaluation of adverse reaction observed after immunization.
Parole chiave
Adverse reaction AEFI Immunization Immunizzazione Reazione avversa Sorveglianza vaccinale Vaccine surveillance Vaccines Vaccini
Classificazione MeSH
Health Care Facilities Workforce and Services Health Services Pharmaceutical Services Drug Information Services Adverse Drug Reaction Reporting Systems (10)
Chemically-Induced Disorders Drug-Related Side Effects and Adverse Reactions (116)
Therapeutics Biological Therapy Immunomodulation Immunotherapy Immunization (14)
Investigative Techniques Evaluation Studies as Topic Product Surveillance, Postmarketing Pharmacovigilance (24)
Investigative Techniques Evaluation Studies as Topic Product Surveillance, Postmarketing (4)
Therapeutics Biological Therapy Immunomodulation Immunotherapy Immunization Immunotherapy, Active
Leggi anche
RI Pagine elettroniche
Analisi delle sospette reazioni avverse alle vaccinazioni nella popolazione pediatrica
C. Santuccio, L. Tartaglia, F. Trotta, R. Da Cas, · 2013
Product Surveillance, Postmarketing, Adverse Drug Reaction Reporting Systems, Immunization, Pharmacovigilance
EL Ricerca
Analisi delle sospette reazioni avverse alle vaccinazioni nella popolazione pediatrica
C. Santuccio, L. Tartaglia, F. Trotta, R. Da Cas, · 2013
Product Surveillance, Postmarketing, Adverse Drug Reaction Reporting Systems, Immunization, Pharmacovigilance/Product Surveillance, Postmarketing
RI Focus
L’importanza dei case report in farmacovigilanza
M. Venegoni · 2009
Product Surveillance, Postmarketing/Adverse Drug Reaction Reporting Systems, Adverse Drug Reaction Reporting Systems, Pharmacovigilance, Drug-Related Side Effects and Adverse Reactions
RI Editoriali
La farmacovigilanza a servizio dei bambini e dei pediatri Chikungunya: diagnosticare una nuova infez...
· 2007
Product Surveillance, Postmarketing/Adverse Drug Reaction Reporting Systems, Adverse Drug Reaction Reporting Systems, Pharmacovigilance, Drug-Related Side Effects and Adverse Reactions
RI Editoriali
Reazioni avverse ai farmaci:vigilanza attiva e “ragionevole vigilanza”
F. Marchetti · 2009
Product Surveillance, Postmarketing/Adverse Drug Reaction Reporting Systems, Adverse Drug Reaction Reporting Systems, Pharmacovigilance, Drug-Related Side Effects and Adverse Reactions
Contenuto riservato

Per leggere l'articolo completo è necessario effettuare il login.

Non sei ancora registrato? Registrati

Bibliografia
1. http://www.who.int/vaccine_safety/publications/ gvs_aefi/en/. 2. http://www.agenziafarmaco.gov.it/it/content/ istituito-gruppo-di-lavoro-la-vaccinovigilanza- 01082014. 3. http://www.agenziafarmaco.gov.it/it/content/ guida-alla-valutazione-delle-reazioni-avverse- osservabili-dopo-vaccinazione. 4. https://brightoncollaboration.org/public. 5. http://sip.it/wp-content/uploads/2011/ 06/ lineeguidaALTE-corretto-1-3.pdf. 6. Sellner J, Boggild M, Clanet M, et al. EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol 2010;17(8): 1019-32. 7. Dhami S, Panesar SS, Roberts G, et al.; EAACI Food Allergy and Anaphylaxis Guidelines Group. Management of anaphylaxis: a systematic review. Allergy 2014;69(2):168-75. 8. Council for International Organizations of Medical Sciences (CIOMS). Definition and application of terms of vaccine pharmacovigilance (report of CIOMS/WHO Working Group on Vaccine Pharmacovigilance). Genève: CIOMS; 2012. 9. Van Alfen N. The neuralgic amyotrophy consultation. J Neurol 2007;254(6):695-704. 10. De La Cruz J, Kupersmith MJ. Clinical profile of simultaneous bilateral optic neuritis in adults. Br J Ophtalmol 2006;90(5):551-4. 11. Baugh RF, Basura GJ, Ishii LE, et al. Clinical Palsy Guideline: Bell’s Palsy. Otolaryngol Head Neck Surg 2013;149(3 Suppl):S1-27. 12. Jennette JC. Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Clin Exp Nephrol 2013;17(5):603-6. 13. Ruggeberg JU, Gold MS, Bayas JM, et al.; Brighton Collaboration Anaphylaxis Working Group. Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine 2007;25(31):5675-84. 14. Bohlke K, Davis RI, Marcy SM, et al. Risk of anaphylaxis after vaccination of children and adolescent. Pediatrics 2003;112:815-20. 15. Jorch G, Tapiainen T, Bonhoeffer J, et al.; Brighton Collaboration Unexplained Sudden Death Working Group. Unexplained sudden death, including sudden infant death syndrome (SIDS), in the first and second years of life: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2007;25(31):5707-16.

Corrispondenza: p.felicetti@aifa.gov.it